Achlys In Silico
Achlys has developed a novel In Silico method for better predicting cardiotoxicity of small molecule drug candidates. By providing more and better predicative data, Achlys can provide better risk assessment, drug salvaging, and optimization based on better predictive hERG binding.
Using state-of-art supercomputing techniques, Achlys has produced the most useful In Silico model of the hERG ion channel to date. This tool should improve the safety, efficiency and speed of your drug development program.